Schedule 13G ownership disclosure
LARIMAR THERAPEUTICS INC
Security class unavailable · CUSIP: 517125100
Event date: 2022-02-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 943,702
- Percent of class
- 5.3200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-22-004967
- Form type
- SC 13G
- Filer
- Larimar Therapeutics, Inc.
- CIK
- CIK 1374690
- Filed
- Feb 18, 2022
- Reporting period
- Feb 15, 2022
- Description
- Schedule 13G beneficial ownership